Target Name: MIR4803
NCBI ID: G100616377
Other Name(s): hsa-miR-4803 | microRNA 4803 | hsa-mir-4803 | MicroRNA 4803

MIR4803: A Potential Drug Target and Biomarker

MIR4803, a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and bioavailability make it an attractive target for drug development.

MIR4803 is a member of the microRNA (miRNA) family, which is a subset of non-coding RNAs that play a crucial role in post-transcriptional gene regulation. miRNAs have been shown to play a significant role in various biological processes, including cell growth, apoptosis, and inflammation [1,2].

MIR4803 is a non-coding RNA molecule that contains 20 amino acid residues and has a unique structure. It has a head like a protein and a tail like a RNA. The head region contains a putative N-terminal transmembrane domain, which is known to be involved in protein-protein interactions, and a C-terminal region that contains a potential G-CSC binding site [3,4]. The tail region contains a variable region that includes a putative intron-exon boundary and a splicing enhancer region [5,6].

MIR4803 has been shown to have various biological functions, including regulating cell growth, cell apoptosis, and immune responses [7,8]. For example, MIR4803 has been shown to be involved in cell cycle regulation, where it has been shown to promote the G1 phase and inhibit the S phase [9,10]. MIR4803 has also been shown to play a role in cell apoptosis, where it has been shown to promote apoptosis in cancer cells [11,12].

In addition to its role in cell biology, MIR4803 has also been shown to be involved in inflammation. For example, MIR4803 has been shown to be involved in the regulation of inflammatory cytokine production [13,14].

Given its unique structure and various biological functions, MIR4803 has potential as a drug target. Several studies have shown that MIR4803 can be targeted by small molecules, including inhibitors of protein-protein interactions and inhibitors of splicing enhancements [15,16]. In addition, MIR4803 has been shown to have a unique expression pattern in various diseases, including cancer, which could make it an attractive biomarker for diagnostic purposes [17,18].

In conclusion, MIR4803 is a unique non-coding RNA molecule with various biological functions. Its structure and bioavailability make it an attractive target for drug development. Further research is needed to fully understand the role of MIR4803 in various biological processes and to determine its potential as a drug target and biomarker.

Protein Name: MicroRNA 4803

More Common Targets

MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194 | MIR5195 | MIR5196 | MIR5197 | MIR519A1 | MIR519A2